Endoscopic Retrograde Cholangiopancreatography (ERCP) Market By Product Type (Endoscopes, Stents, Cannulas, Forceps, Sphincterotomes, Others); By Application (Biliary Diseases, Pancreatic Diseases, Others); By End-User (Hospitals, Ambulatory Surgical Centres (ASCs), Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The market size of ERCP was USD 1.4 billion in 2023 and will be USD 2.2 billion by 2030, at a CAGR of 6.8%. Such growth is attributed to the expanding incidence of pancreaticobiliary diseases, the growing need for minimally invasive diagnostic methods, and developments in endoscopies.

&... Read More

Uterine Fibroids Treatment Devices Market By Treatment Type (Minimally Invasive Procedures (Laparoscopic Myomectomy, Radiofrequency Ablation (RFA), Hysteroscopic Myomectomy), Non-Invasive Procedures (Focused Ultrasound), Surgical Procedures (Hysterectomy)); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The uterine fibroids treatment devices market was USD 4.8 billion in 2023 and is expected to reach USD 8.2 billion by 2030 at an average CAGR of 7.8% by the end of the projections period. Market growth is propelled by new developments in the medical field, growing consciousness of female health, ... Read More

Plaque Modification Devices Market By Product Type (Atherectomy Devices (Rotational Atherectomy Devices, Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices), Thrombectomy Devices, Specialty Catheters, Others); By Application (Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The global plaque modification devices market was USD 1.1 billion in 2023 and is expected to reach USD 1.9 billion by 2030, growing at a CAGR of 7.4%. The market growth is due to increasing incidence of cardiovascular diseases, increased proportion of older people, and improved technology.

Peripheral Vascular Devices Market By Product Type (Stents, Angioplasty Balloons, Catheters, Vascular Grafts, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Other Devices); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The global peripheral vascular devices market was valued at $11.8 billion in 2023 and is forecasted to reach $18.5 billion by 2030 at a compound annual growth rate of 6.5%. The market drivers include the rising peripheral vascular diseases, innovative minimally invasive techniques, and an enhance... Read More

Elbow Replacement Market By Product Type (Total Elbow Replacement Implants, Partial Elbow Replacement Implants, Revision Elbow Replacement Implants); By Material (Metal-Based Implants (Titanium, Cobalt-Chromium Alloys), Polymer-Based Implants (Polyethylene, PEEK), Ceramic-Based Implants); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Orthopedic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The elbow replacement market was USD 345 million in 2023 and will reach USD 550 million by 2030 at a CAGR of 6.8% during the forecast period. Market growth factors include the increased incidence of osteoarthritis and rheumatoid arthritis, improving joint implant technology, and increasing joint ... Read More

Liver Disease Therapeutics Market By Product Type (Antiviral Drugs, Immunosuppressants, Corticosteroids, Chemotherapy Drugs, Biologics, Gene Therapies, Others (e.g., stem cell therapies)); By Application (Hepatitis, Non-Alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Cancer, Cirrhosis, Others (e.g., Wilson’s disease, hemochromatosis)); By Distribution Channel (Hospitals and Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The liver disease therapeutics market was worth USD 18.7 billion in 2023 and is expected to reach ,  USD 33.5 billion at a CAGR of 8.6% by 2030. Biochemical changes in human bodies, development of allied biotechnology, and global awareness towards various chronic liver diseases, earlier diag... Read More

Image Guided Surgery Devices Market By Product Type (Surgical Navigation Systems, Endoscopes, Surgical Robots, CT, MRI, and Ultrasound-Based IGS Systems, Others); By Application (Neurosurgery, Orthopedic Surgery, Oncology Surgery, Cardiovascular Surgery, ENT Surgery, Others); By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The image-guided surgery devices market was valued USD 5.2 billion in 2023 and estimated to reach USD 10.8 billion by 2030, at a Compound Annual Growth Rate of 11.2%. The growing incidence of chronic conditions, along with the progression of MSS techniques, underlines the necessity of IGS devices... Read More

Brain Tumor Diagnosis and Therapeutics Market By Diagnosis Type (Imaging Techniques (MRI (Magnetic Resonance Imaging), CT (Computed Tomography), PET (Positron Emission Tomography), Other Imaging Techniques), Biopsy, Molecular Diagnostics); By Therapeutics Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy); By Tumor Type (Glioblastoma, Meningioma, Pituitary Tumors, Astrocytomas, Other Tumors); By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers (ASCs), Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The global brain tumor diagnosis and therapeutics market was worth USD 5.5 billion in 2023 and is expected to reach USD 9.7 billion by 2030 with CAGR of 8.3%. This growth is due to the rising cases of brain tumors, the general increase in health care costs, and improvement to the techniques used ... Read More

Joint Reconstruction Devices Market By Product Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Shoulder Reconstruction Devices, Small Joint Reconstruction Devices (elbow, wrist, and ankle)); By Material (Metal-Based Implants (titanium, cobalt-chromium alloys), Ceramic-Based Implants, Polymer-Based Implants); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Orthopedic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The joint reconstruction devices market was USD 21.5 billion in 2023 and is expected to reach USD 34.8 billion at a CAGR of 7.1 % from 2023 to 2030. The major driving forces of this growth are new trends in implant technology, increasing incidence of joint disorders, and enhanced awareness of joi... Read More

Implantable Cardioverter Defibrillator (ICD) Market By Product Type (Transvenous ICDs, Single-Chamber ICDs, Dual-Chamber ICDs, Subcutaneous ICDs (S-ICDs)); By End-User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Distribution Channel (Direct Purchase, Third-Party Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

The implantable cardioverter defibrillator (icd) market was $7.1 billion in 2023 and is expected to reach $10.9 billion by 2030 at a CAGR of 6.3%. The market growth is attributed to factors such as raising incidence of CVDs, development in the ICD devices and increasing concern among people regar... Read More